Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Vaccination in Prostate Cancer (VANCE)
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Fasting on Newly Diagnosed Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Peginterferon and TIL Therapy for Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Investigator Initiated Phase 1 Study of TBI-1301
- Status
- UNKNOWN
- Phase
- PHASE1
CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE3
GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant
- Status
- TERMINATED
- Phase
- NA
Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage
- Status
- TERMINATED
- Phase
- PHASE3
A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors
- Status
- SUSPENDED
- Phase
- PHASE1
Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT
- Status
- TERMINATED
- Phase
- PHASE2
Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301)
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of DPX-Survivac Vaccine Therapy in Patients With Recurrent Survivin-expressing DLBCL
- Status
- TERMINATED
- Phase
- PHASE2